This estimate is based on the fact that the company has make a significant progress in the past days within its drug pipline.
Now the company is a potential take over target.
There is a gap at 0.42 USD - but as soons as this gap has been closed - the stock is able to pop up to the upside.
A small entry order can be placed as market order in order to get a step into the door, if the PPS is starting higher. If the stock will override the 1 USD mark for more than 10 consecutive days the longterm sentiment should lead to a bias change at this stock.